ER Progression and Resistance: Causes, Consequences, and Hope
Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife

ER Progression and Resistance: Causes, Consequences, and Hope

Endocrine therapy is an effective way to treat hormone-sensitive breast cancers, but de novo and acquired resistance to this treatment remains a major challenge. In this episode, the Our MBC Life team hears from two dynamic MSK oncologists Dr. Pedram Razavi and Dr. Komal Jhaveri on treatment strategies and the latest research around the problem of endocrine resistance.

Read More
Report Back from SABCS 2021: What’s the Latest in MBC Research?
Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife

Report Back from SABCS 2021: What’s the Latest in MBC Research?

Learn about the most recent information released at the annual San Antonio Breast Cancer Symposium regarding metastatic breast cancer research with Dr. Peter Schmid, Professor of Cancer Medicine at Barts Cancer Institute in London, England. Dr. Schmid will provide a comprehensive update and answer your questions about these new developments.

Read More
Road to a Cure - drug resistance
Entities of Cancer, Novel Treatments, Medical Community, Diagnosis and Treatment, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Translational Research Our MBClife Entities of Cancer, Novel Treatments, Medical Community, Diagnosis and Treatment, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Translational Research Our MBClife

Road to a Cure - drug resistance

It is fitting that our 7th and last stop before the SABCS is back to NYC. Co-hosts Lisa Laudico and Ellen Landsberger talk with Dr Sarat Chandarlapaty, a leading Physician Scientist at MSKCC. As both a physician treating patients and a scientist in the lab, Dr. Chandarlapaty gives us an understanding of translational medicine, transferring what he learns from his patients back into the lab to answer questions that advance the treatment of metastatic breast cancer.

Read More
Road to a Cure - ABC with Dr. Fatima Cardoso
Novel Treatments, Medical Community, BC Policies and Legislation, Clinical Trials Process, Health Disparities, Diagnosis and Treatment, Entities of Cancer, Precision Oncology, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Basic Science, Translational Research Our MBClife Novel Treatments, Medical Community, BC Policies and Legislation, Clinical Trials Process, Health Disparities, Diagnosis and Treatment, Entities of Cancer, Precision Oncology, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Basic Science, Translational Research Our MBClife

Road to a Cure - ABC with Dr. Fatima Cardoso

This is the sixth stop in our series Road to a Cure. From the start our goal for this series was not only to educate and give hope to every listener but also to ensure that each of these special interviews feels like an intimate conversation with our smartest friend who also happens to be an oncologist researcher. This episode will not disappoint., Co-hosts Victoria Goldberg and Lisa Laudico, sit down with the Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, Dr. Fatima Cardoso.

Read More
All About Lobular Breast Cancer
MBC Allies, Medical Community, Entities of Cancer, Essential Knowledge, Difficult to Treat, Obstacles to Better Outcomes, Diagnosis and Treatment, MBC Imaging and Profiling, Clinical Research, Translational Research, Novel Treatments Our MBClife MBC Allies, Medical Community, Entities of Cancer, Essential Knowledge, Difficult to Treat, Obstacles to Better Outcomes, Diagnosis and Treatment, MBC Imaging and Profiling, Clinical Research, Translational Research, Novel Treatments Our MBClife

All About Lobular Breast Cancer

Did you know that not ALL breast cancer can be detected by a lump? We are joined by Laurie Hutcheson of the Lobular Breast Cancer Alliance and researchers Steffi Oesterreich, PhD and Adrian Lee, PhD why ILC is difficult to research and what looks promising for the future.

Read More